TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
RLYB

Rallybio Corp

Healthcare · Biotechnology

17.20$ +0.0% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow RLYB
Line item 2019 2020 2021 2022 2023 2024 2025
– – – – – -7,748.7% -3,474.7%
– – – – – 20.6% 10.7%
– – – – – 1,256.8% 619.3%
– – – – – -40.6% -488.6%
– – – – – 0.0% 0.0%
– – – – – 5,266.0% 5,509.1%
– – – – – 9.7% 1.9%
– – – – – 817.5% 1.9%
– – – – – -1,665.3% 2,036.2%
– – – – – -7,748.7% -3,474.7%

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?